Landauer Inc. (LDR) Stock Analysis
DELISTED 2017
What happened to Landauer Inc. (LDR) stock?
Landauer Inc. (LDR) no longer trades on public markets. It was delisted in October 2017. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Landauer Inc. (LDR) trades at $67.20. Landauer Inc. , now integrated into Fortive, is a leading provider of personnel radiation monitoring and dosimetry services. Sector: Healthcare.
Last analyzed: Jun 15, 2026Analyst Coverage for LDR: LDR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LDR against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
LDR: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.
How is this calculated? →Landauer Inc. (LDR) Healthcare & Pipeline Overview
Landauer Inc., a key player in radiation safety and dosimetry services, offers personnel radiation monitoring solutions to healthcare, research, and industrial sectors. Operating with an established market presence and a recurring subscription-based revenue model, the company focuses on ensuring compliance and safety in environments exposed to radiation.
What Is the Investment Thesis for LDR?
Landauer Inc. presents a stable investment profile within the specialized radiation safety market, driven by its established market presence and a robust recurring revenue model from subscription-based dosimetry services. The company's integration into Fortive provides a strong corporate backing and potential for synergistic growth. Financially, Landauer exhibits a P/E ratio of 36.06, a profit margin of 11.9%, and a gross margin of 50.6%, indicating solid profitability and efficient operations within its niche. Its beta of 1.25 suggests moderate volatility relative to the broader market. Key growth catalysts include the increasing global demand for radiation safety across expanding healthcare infrastructure and industrial applications, coupled with evolving regulatory standards that mandate stringent monitoring. However, the investment thesis must account for ongoing risks such as potential technological advancements disrupting traditional dosimetry methods and increasing competition from both specialized firms and larger diversified technology companies. Investors should closely monitor Landauer's strategic initiatives to adapt to new radiation detection technologies and its ability to maintain market leadership amidst a dynamic industry landscape.
Based on FMP financials and quantitative analysis
LDR Key Highlights
Gross Margin of 50.6% demonstrates strong operational efficiency and pricing power within its specialized dosimetry services.
- Profit Margin of 11.9% indicates healthy profitability, reflecting effective cost management relative to revenue.
- P/E ratio of 36.06 suggests investor confidence in future earnings potential, aligning with its established market position and recurring revenue.
- Beta of 1.25 indicates that Landauer's stock tends to be moderately more volatile than the overall market, offering potential for higher returns but also higher risk.
- Recurring revenue model from subscription-based personnel radiation monitoring provides predictable cash flows and enhances long-term financial stability.
Who Are LDR's Competitors?
LDR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SIRO Sirona Dental Systems, Inc. | $109.97 | -0.03% | $22.0B | 43 |
| HIMS Hims & Hers Health, Inc. | $31.86 | +2.48% | $7.11B | 34 |
| CON Concentra Group Holdings Parent, Inc. | $34.81 | +0.12% | $4.45B | 76 |
| NVST Envista Holdings Corp. | $26.93 | -2.36% | $4.38B | 95 |
| BBNX Beta Bionics, Inc. | $19.48 | -2.65% | $876M | — |
| CV CapsoVision, Inc. | $5.91 | -3.43% | $295M | — |
| NAKA Kindly MD, Inc. | $6.30 | +3.96% | $110M | — |
| PARK Park Dental Partners, Inc. | $21.68 | +2.26% | $97.9M | 38 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LDR's Key Strengths?
Established market presence and leadership in dosimetry services.
- Strong recurring revenue model from subscription-based monitoring.
- High gross margin (50.6%) indicating efficient operations and pricing power.
- Integration into Fortive provides substantial corporate backing and resources.
What Are LDR's Weaknesses?
Vulnerability to technological advancements that could disrupt traditional dosimetry methods.
- Potential for increasing competition from new entrants or existing players.
- Reliance on specific niche market demand for radiation safety.
- Beta of 1.25 suggests moderate market volatility.
What Could Drive LDR Stock Higher?
LDR catalyst: Increasing global focus on worker safety and environmental protection, driving demand for robust radiation monitoring.
- Evolution of international radiation safety standards, potentially mandating more frequent or advanced monitoring services.
- Successful integration and synergy realization within Fortive, leading to enhanced operational efficiencies and market reach.
- Introduction of next-generation dosimetry technologies that offer improved accuracy or real-time monitoring capabilities.
What Are the Key Risks for LDR?
Technological advancements in radiation detection that could render traditional dosimetry methods less competitive or obsolete.
- Increasing competition in the specialized dosimetry market, potentially leading to pricing pressures and reduced market share.
- Failure to adapt quickly to evolving industry standards and regulatory requirements for radiation safety.
- Economic downturns impacting healthcare, research, and industrial sectors, which could reduce spending on safety services.
- Supply chain disruptions affecting the availability of components for dosimeters or processing equipment.
What Are the Growth Opportunities for LDR?
- **Expansion in Global Healthcare Infrastructure:** The global healthcare sector is experiencing significant growth, particularly in emerging markets, leading to increased demand for diagnostic imaging, radiation therapy, and interventional procedures. This expansion directly translates into a greater need for robust personnel radiation monitoring services. As new hospitals and clinics are established and existing facilities upgrade their equipment, the requirement for Landauer's dosimetry solutions will grow, providing a substantial market opportunity for geographic and client base expansion. This trend is ongoing and expected to continue for the foreseeable future, driven by demographic shifts and improving access to medical care worldwide.
- **Adoption of Advanced Dosimetry Technologies:** The radiation safety industry is continuously evolving with technological advancements, including the development of more sophisticated and efficient radiation detection methods. Landauer has an opportunity to invest in and integrate these newer technologies, such as real-time electronic dosimeters or advanced passive dosimetry systems, into its service offerings. By leading in technological innovation, the company can enhance the accuracy, speed, and convenience of its monitoring services, attracting new clients and solidifying its competitive edge against traditional methods. This ongoing evolution in technology presents a pathway for sustained product and service differentiation.
- **Increasing Regulatory Scrutiny and Compliance Needs:** Governments and international bodies are consistently updating and tightening radiation safety regulations to protect workers and the public. These evolving standards often mandate more frequent, precise, and comprehensive radiation monitoring. Landauer, with its expertise and established compliance infrastructure, is well-positioned to capitalize on this trend. The heightened regulatory environment creates a non-discretionary demand for its services, as organizations must comply to avoid penalties and ensure worker safety, thereby providing a stable and growing market for Landauer's specialized solutions.
- **Diversification of Service Offerings:** Beyond traditional personnel dosimetry, Landauer can explore opportunities to diversify its service portfolio to offer more comprehensive radiation safety solutions. This could include environmental radiation monitoring, consulting services for radiation safety program development, or specialized training programs for radiation workers. Expanding into these adjacent areas would allow Landauer to capture a larger share of the overall radiation safety market, create new revenue streams, and deepen its relationships with existing clients by becoming a more holistic safety partner. This strategic diversification could unfold over the medium to long term.
- **Leveraging Fortive's Global Reach and Synergies:** As part of Fortive, Landauer has access to a broader global distribution network, shared technological resources, and potential cross-selling opportunities with other Fortive operating companies. This integration allows Landauer to accelerate its geographic expansion into new international markets where Fortive already has a strong presence, reducing market entry barriers. Furthermore, leveraging Fortive's R&D capabilities and operational best practices can enhance Landauer's efficiency and innovation, driving organic growth and market penetration. This ongoing synergy within the larger corporate structure provides a significant competitive advantage and growth pathway.
What Are LDR's Competitive Advantages?
- Established market presence and reputation built over years of specialized service in radiation safety.
- Recurring revenue model from long-term subscription contracts for monitoring services.
- Specialized technical expertise and proprietary technology in dosimetry and radiation measurement.
- High barriers to entry due to stringent regulatory requirements and the need for specialized infrastructure and certifications.
- Integration into Fortive, providing access to broader resources, R&D, and global market reach.
What Does LDR Do?
Landauer Inc. has historically been a prominent entity in the specialized field of radiation safety, primarily focusing on personnel radiation monitoring and dosimetry services. Founded with the mission to protect individuals working in environments with potential radiation exposure, the company developed and refined technologies for accurately measuring and tracking radiation doses. Over its operational history, Landauer established itself as a major player, building a reputation for reliability and precision in its core offerings. The company's evolution saw it become an integral part of Fortive, a diversified industrial technology conglomerate, which further solidified its market position and provided access to broader resources and global reach. Landauer's primary products and services revolve around providing dosimeters—small devices worn by individuals—that measure cumulative radiation exposure. These devices are then processed and analyzed by Landauer, providing critical data for compliance with safety regulations and protecting workers. Their services are crucial across a diverse range of sectors, including healthcare (hospitals, clinics, imaging centers), research institutions (laboratories, universities), and various industrial applications (nuclear power plants, manufacturing facilities using radioactive materials). The business model is largely characterized by a recurring revenue stream, as customers typically subscribe to ongoing monitoring services, ensuring consistent demand for Landauer's expertise and technology. This established market presence and essential service offering underscore Landauer's critical role in maintaining safety standards in radiation-intensive environments globally.
What Products and Services Does LDR Offer?
- Provides personnel radiation monitoring services to measure individual exposure to radiation.
- Offers dosimetry services, which involve the use of specialized devices (dosimeters) to track radiation doses.
- Serves a diverse client base including healthcare facilities, research institutions, and industrial operations.
- Collects, processes, and analyzes dosimeters to provide critical radiation exposure data.
- Helps organizations comply with radiation safety regulations and protect their workforce.
- Maintains an established market presence in the radiation safety industry.
- Operates on a recurring revenue model, primarily through subscription-based monitoring services.
How Does LDR Make Money?
- Subscription-based services for personnel radiation monitoring, providing recurring revenue.
- Sales and leasing of various types of dosimeters and associated equipment.
- Data analysis and reporting services based on collected radiation exposure information.
- Providing compliance solutions and expert support for radiation safety programs.
What Industry Does LDR Operate In?
Landauer Inc. operates within the critical and highly specialized Medical Equipment & Services industry, specifically focusing on radiation safety and dosimetry. This segment is characterized by stringent regulatory requirements and a constant need for precise, reliable monitoring solutions. The broader healthcare sector, along with research and industrial applications, represents a growing market for radiation protection, driven by advancements in medical imaging, radiation therapy, and industrial processes utilizing radioactive materials. Landauer holds an established position as a major player in dosimetry services, benefiting from a recurring revenue model that provides stability. The competitive landscape includes other specialized dosimetry providers and larger industrial safety companies with radiation monitoring divisions. Key market trends include the increasing adoption of digital dosimetry, demand for real-time monitoring, and the continuous evolution of international radiation safety standards, all of which influence Landauer's strategic direction and product development.
Who Are LDR's Key Customers?
- Hospitals, clinics, and medical imaging centers requiring radiation safety for staff and patients.
- Research institutions and universities conducting studies involving radioactive materials.
- Industrial facilities such as nuclear power plants, manufacturing, and NDT (Non-Destructive Testing) companies.
- Government agencies and defense organizations with personnel exposed to radiation.
- Any organization where employees may be exposed to ionizing radiation.
Company Profile
Landauer Inc. operates in the Medical - Equipment & Services industry within the Healthcare sector. LDR has traded publicly since 1992.
Key Financial Metrics
Return on equity for Landauer Inc. stands at 116.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.3%, showing how much profit it generates from its asset base. LDR trades at a trailing price-to-earnings ratio of 36.06, above the Healthcare sector average of ~23x. A current ratio of 1.62 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.8%, the inverse of the P/E and a quick read on earnings relative to price.
LDR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established market presence and leadership in dosimetry services.
- Strong recurring revenue model from subscription-based monitoring.
- High gross margin (50.6%) indicating efficient operations and pricing power.
- Integration into Fortive provides substantial corporate backing and resources.
Bear Case
- Vulnerability to technological advancements that could disrupt traditional dosimetry methods.
- Potential for increasing competition from new entrants or existing players.
- Reliance on specific niche market demand for radiation safety.
- Beta of 1.25 suggests moderate market volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
LDR Latest News
No recent news available for LDR.
LDR Healthcare Stock FAQ
What happened to Landauer Inc. (LDR) stock?
Landauer Inc. (LDR) no longer trades on public markets. It was delisted in October 2017. The figures below are historical and are not a current quote.
Can I still buy LDR shares?
No. LDR stopped trading on public markets in October 2017, so the shares are not available through a broker. Anything you see quoted for LDR elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LDR stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Landauer Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Landauer Inc. do?
Landauer Inc. specializes in providing essential radiation safety products and services, primarily focusing on personnel radiation monitoring. The company offers a comprehensive suite of dosimetry solutions, which involve distributing specialized devices (dosimeters) to individuals working in environments with potential radiation exposure. These devices are then collected, processed, and meticulously analyzed by Landauer to accurately measure and track cumulative radiation doses.
What revenue streams does Landauer Inc. have in healthcare?
In the healthcare sector, Landauer Inc. primarily generates revenue through its subscription-based personnel radiation monitoring services. This involves providing dosimeters to medical professionals, technicians, and support staff in hospitals, clinics, diagnostic imaging centers (e.g., X-ray, CT, MRI with radiation components), and radiation therapy facilities (e.g., oncology departments).
How does Landauer Inc. navigate regulatory compliance in radiation safety?
Landauer Inc. navigates regulatory compliance in radiation safety by adhering to a complex framework of national and international standards, such as those set by the Nuclear Regulatory Commission (NRC) in the U.S., the International Atomic Energy Agency (IAEA), and various national health and safety bodies.
What are the main risks for LDR?
The main risks for Landauer Inc. (LDR) are multifaceted and primarily revolve around technological disruption and market competition. A significant ongoing risk is the potential for rapid technological advancements in radiation detection that could render traditional dosimetry methods less competitive or even obsolete.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- No FMP PEER TICKERS were provided, so competitors are listed as 'Unknown'.
- Specific market sizes and timelines for growth opportunities were inferred from general industry trends and company business model, as specific data was not provided in the source. Care was taken to avoid speculative numbers.
- No CEO profile data was provided, so the 'ceoProfile' object is null.
- No analyst ratings or consensus data was provided, so the relevant FAQ was omitted.